35 related articles for article (PubMed ID: 24676971)
1. New insights on scleromyxedema.
Atzori L; Ferreli C; Rongioletti F
J Scleroderma Relat Disord; 2019 Jun; 4(2):118-126. PubMed ID: 35382389
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of dermato-neuro syndrome with plasmapheresis.
Larios JM; Ciuro J; Sam Varghese T; Lyons SE
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33376089
[TBL] [Abstract][Full Text] [Related]
3. [Mimetics of systemic sclerosis].
Jendrek ST; Kahle B; Riemekasten G
Z Rheumatol; 2019 Feb; 78(1):14-23. PubMed ID: 30255410
[TBL] [Abstract][Full Text] [Related]
4. [Scleromyxedema].
Neufeld M; Sunderkötter C; Moritz RKC
Hautarzt; 2018 Nov; 69(11):916-921. PubMed ID: 30135969
[TBL] [Abstract][Full Text] [Related]
5. Scleroderma Mimickers.
Morgan ND; Hummers LK
Curr Treatm Opt Rheumatol; 2016 Mar; 2(1):69-84. PubMed ID: 28473954
[TBL] [Abstract][Full Text] [Related]
6. Acute Encephalitic Syndrome Induced by Scleromyxedema.
Magira EE; Malouchou A; Karathanasi V; Mavropoulou N; Siempos II; Vourlakou C; Sykaras A; Anastasiadis G
Am J Med Sci; 2020 Aug; 360(2):192-195. PubMed ID: 32540147
[TBL] [Abstract][Full Text] [Related]
7. [Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].
Bielsa I; Benvenutti F; Guinovart RM; Ferrándiz C
Actas Dermosifiliogr; 2012 May; 103(4):317-20. PubMed ID: 21917233
[TBL] [Abstract][Full Text] [Related]
8. Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.
Shams SR; Goldstein DA; Kaufman JL; MacKelfresh J; Flowers CR; Langston AA
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e213-5. PubMed ID: 25065780
[No Abstract] [Full Text] [Related]
9. Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation.
Chockalingam R; Duvic M
Int J Dermatol; 2016 Oct; 55(10):e539-43. PubMed ID: 27207484
[TBL] [Abstract][Full Text] [Related]
10. Dermato-neuro syndrome associated with scleromyxedema.
Karaman B; Guler A; Ertam I; Celebisoy N
Indian J Dermatol Venereol Leprol; 2015; 81(5):519-21. PubMed ID: 26261151
[No Abstract] [Full Text] [Related]
11. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
12. Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years.
Devos T; Thiessen S; Cuyle PJ; Meersseman W; Delforge M
Ann Hematol; 2014 Nov; 93(11):1927-8. PubMed ID: 24676971
[No Abstract] [Full Text] [Related]
13. Scleromyxedema.
Hummers LK
Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
